Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.735 USD | +5.00% | -8.12% | -30.00% |
03-18 | Pharma-Bio Serv, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
01-30 | Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About February 15, 2024 | CI |
Sales 2024 * | 12.8M 1.02B | Sales 2025 * | 20.2M 1.61B | Capitalization | 16.88M 1.35B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.32 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.84 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 34.4% |
1 day | +5.00% | ||
1 week | -8.12% | ||
Current month | -13.22% | ||
1 month | -13.22% | ||
3 months | -29.33% | ||
6 months | -13.53% | ||
Current year | -30.00% |
Managers | Title | Age | Since |
---|---|---|---|
Victor Sanchez
CEO | Chief Executive Officer | 53 | 31/12/10 |
Pedro Lasanta
DFI | Director of Finance/CFO | 64 | 04/11/07 |
Sandra Molina
COO | Chief Operating Officer | - | 31/12/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dov Perlysky
BRD | Director/Board Member | 61 | 31/12/03 |
Kirk Michel
CHM | Chairman | 68 | 24/01/06 |
Howard Spindel
BRD | Director/Board Member | 78 | 24/01/06 |
Date | Price | Change | Volume |
---|---|---|---|
25/04/24 | 0.735 | +5.00% | 5,317 |
Delayed Quote OTC Markets, April 25, 2024 at 06:28 pm
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.00% | 16.88M | |
+6.80% | 7.41B | |
-32.64% | 3.24B | |
+6.75% | 2.66B | |
+11.38% | 1.75B | |
-9.32% | 1.08B | |
+31.69% | 907M | |
-7.64% | 714M | |
-3.38% | 606M | |
-8.30% | 539M |
- Stock Market
- Equities
- PBSV Stock